Nexgel (NXGL) EBITDA Margin (2018 - 2025)
Nexgel (NXGL) recorded EBITDA Margin of -39.41% in Q4 2025, down 15.31 percentage points from -24.10% a year earlier and down 18.55 percentage points from the prior quarter.
Powered by 
Analysis
Nexgel (NXGL) EBITDA Margin (2018 - 2025) Analysis & Trends
For FY2025, Nexgel reported EBITDA Margin of -25.41%, up 10.48 percentage points from FY2024.
- Annual EBITDA Margin has increased for five straight years, with a five-year change of +302.48 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -35.89% in FY2024 (+43.62 pp), -79.51% in FY2023 (+78.50 pp), -158.01% in FY2022 (+0.41 pp) and -158.41% in FY2021 (+169.48 pp).
- The Q4 2025 figure is the lowest quarterly EBITDA Margin since Q2 2024.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of +30.75 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 505.24 percentage points in Q4 2021, against a drop of 40.50 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -20.86% (Q3 2025), -18.20% (Q2 2025) and -23.63% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 46.35 Bn | 38.05 Bn | 1.44 Bn | 18.41% |
| 2 | Medpace Holdings | 18.80 Bn | 16.87 Bn | 201.64 Mn | 21.71% |
| 3 | Charles River Laboratories International | 16.78 Bn | 15.98 Bn | 363.37 Mn | 18.64% |
| 4 | Icon | 14.66 Bn | 11.77 Bn | 479.29 Mn | 11.15% |
| 5 | Fortrea Holdings | 2.27 Bn | 1.65 Bn | 139.20 Mn | 5.07% |
| 6 | Ginkgo Bioworks Holdings | 607.90 Mn | -154.18 Mn | 18.44 Mn | -229.38% |
| 7 | Evotec SE | 548.72 Mn | -1.06 Bn | - | - |
| 8 | Champions Oncology | 66.95 Mn | 42.60 Mn | 7.70 Mn | -0.62% |
| 9 | MindWalk Holdings | 56.59 Mn | 20.24 Mn | 1.61 Mn | -152.92% |
| 10 | Nexgel | 2.37 Mn | -2.05 Mn | 1.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -39.41% |
| Sep 30, 2025 | -20.86% |
| Jun 30, 2025 | -18.20% |
| Mar 31, 2025 | -23.20% |
| Dec 31, 2024 | -24.10% |
| Sep 30, 2024 | -20.54% |
| Jun 30, 2024 | -67.50% |
| Mar 31, 2024 | -63.35% |
| Dec 31, 2023 | -101.29% |
| Sep 30, 2023 | -47.26% |
| Jun 30, 2023 | -62.13% |
| Mar 31, 2023 | -129.52% |
| Dec 31, 2022 | -143.89% |
| Sep 30, 2022 | -135.74% |
| Jun 30, 2022 | -61.32% |
| Mar 31, 2022 | -10.86% |
| Dec 31, 2021 | -19.70% |
| Sep 30, 2021 | 20.90% |
| Jun 30, 2021 | -24.94% |
| Mar 31, 2021 | -144.19% |
API Access
Nexgel EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NXGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NXGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NXGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();